OZEM vs. THNR ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Amplify Weight Loss Drug & Treatment ETF (THNR)

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$27.32

Average Daily Volume

31,803

Number of Holdings ^*

* may have additional holdings in another (foreign) market

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$25.33

Average Daily Volume

2,814

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	OZEM	THNR
30 Days	-0.27%	-4.66%
60 Days	-5.30%	-10.17%
90 Days	3.02%	-2.39%
12 Months

9 Overlapping Holdings

Symbol	Grade	Weight in OZEM	Weight in THNR	Overlap
ALT	D	3.69%	0.18%	0.18%
AMGN	C	3.25%	5.05%	3.25%
AZN	F	4.28%	5.16%	4.28%
LLY	F	15.52%	15.34%	15.34%
NVO	F	17.47%	13.45%	13.45%
OPK	C	1.35%	0.18%	0.18%
PFE	D	3.15%	5.24%	3.15%
TERN	D	2.14%	0.13%	0.13%
VKTX	A	3.69%	2.43%	2.43%

OZEM Overweight 5 Positions Relative to THNR

Symbol	Grade	Weight
SRRK	B	2.62%
REGN	F	2.61%
TAK	C	1.96%
RYTM	D	1.7%
CORT	B	1.43%

OZEM Underweight 6 Positions Relative to THNR

Symbol	Grade	Weight
TMO	D	-4.97%
MRK	F	-4.89%
TEVA	A	-3.75%
WST	B	-3.71%
CTLT	D	-1.89%
HIMS	B	-0.63%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

THNR: Top Represented Industries & Keywords

Industries: Drug Manufacturers - Major Biotechnology Drug Manufacturers - Specialty & Generic Conglomerates Diagnostics & Research Medical Instruments & Supplies